181 related articles for article (PubMed ID: 31524146)
61. CXCR-7 receptor promotes SDF-1α-induced migration of bone marrow mesenchymal stem cells in the transient cerebral ischemia/reperfusion rat hippocampus.
Wang Y; Fu W; Zhang S; He X; Liu Z; Gao D; Xu T
Brain Res; 2014 Aug; 1575():78-86. PubMed ID: 24924806
[TBL] [Abstract][Full Text] [Related]
62. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
[TBL] [Abstract][Full Text] [Related]
63. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
64. High expression of CXCR4 and CXCR7 predicts poor survival in gallbladder cancer.
Yao X; Zhou L; Han S; Chen Y
J Int Med Res; 2011; 39(4):1253-64. PubMed ID: 21986127
[TBL] [Abstract][Full Text] [Related]
65. A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer.
Xu K; He J; Zhang J; Liu T; Yang F; Ren T
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33034614
[TBL] [Abstract][Full Text] [Related]
66. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
[TBL] [Abstract][Full Text] [Related]
67. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.
Gustavsson M; Dyer DP; Zhao C; Handel TM
Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506383
[TBL] [Abstract][Full Text] [Related]
68. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis.
Tanegashima K; Suzuki K; Nakayama Y; Tsuji K; Shigenaga A; Otaka A; Hara T
FEBS Lett; 2013 Jun; 587(12):1731-5. PubMed ID: 23669361
[TBL] [Abstract][Full Text] [Related]
69. Leptin Overexpression as a Poor Prognostic Factor for Colorectal Cancer.
Li C; Quan J; Wei R; Zhao Z; Guan X; Liu Z; Zou S; Wang X; Jiang Z
Biomed Res Int; 2020; 2020():7532514. PubMed ID: 32596369
[TBL] [Abstract][Full Text] [Related]
70. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
71. Expression of the chemokines CXCL12 and CX3CL1 and their receptors in human nerve sheath tumors.
Hattermann K; Li G; Hugo HH; Mentlein R; Mehdorn HM; Held-Feindt J
Histol Histopathol; 2013 Oct; 28(10):1337-49. PubMed ID: 23645563
[TBL] [Abstract][Full Text] [Related]
72. The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.
Freitas C; Desnoyer A; Meuris F; Bachelerie F; Balabanian K; Machelon V
Cytokine Growth Factor Rev; 2014 Jun; 25(3):307-16. PubMed ID: 24853339
[TBL] [Abstract][Full Text] [Related]
73. Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer.
D'Alterio C; Consales C; Polimeno M; Franco R; Cindolo L; Portella L; Cioffi M; Calemma R; Marra L; Claudio L; Perdonà S; Pignata S; Facchini G; Cartenì G; Longo N; Pucci L; Ottaiano A; Costantini S; Castello G; Scala S
Curr Cancer Drug Targets; 2010 Nov; 10(7):772-81. PubMed ID: 20578990
[TBL] [Abstract][Full Text] [Related]
74. CXC receptor 4 and stromal cell-derived factor 1 in primary tumors and liver metastases of colorectal cancer.
Yamada S; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y
J Surg Res; 2014 Mar; 187(1):107-12. PubMed ID: 24238971
[TBL] [Abstract][Full Text] [Related]
75. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
Long P; Sun F; Ma Y; Huang Y
Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
[TBL] [Abstract][Full Text] [Related]
76. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
[TBL] [Abstract][Full Text] [Related]
77. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
Costantini S; Raucci R; De Vero T; Castello G; Colonna G
Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
[TBL] [Abstract][Full Text] [Related]
78. CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives.
Huang X; Hao J; Tan YQ; Zhu T; Pandey V; Lobie PE
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269786
[TBL] [Abstract][Full Text] [Related]
79. The Chemokine CXCL7 is Correlated with LDH-A and Predicts the Prognosis of Patients with Colorectal Cancer.
Liang H; Li L; Huang B; Cheng G; Ao J; Hao S
Front Biosci (Landmark Ed); 2024 Apr; 29(4):166. PubMed ID: 38682188
[TBL] [Abstract][Full Text] [Related]
80. Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Fellhofer-Hofer J; Franz C; Vey JA; Kahlert C; Kalkum E; Mehrabi A; Halama N; Probst P; Klupp F
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
